Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid diagnostics and technologies. Its research is focused on specific areas of the broader diagnostics market, namely the rapid, point-of-care, and in vitro sectors. Its tests are sold globally under the REVEAL, REVEALCOVID-19, Multiplo and Miriad brands. Based on its patented Rapid Vertical Flow Technology, the Company's rapid HIV test has regulatory approvals in Canada, the United States, China and the European Union. Its manufacturing facilities are located in Halifax, Nova Scotia, Canada. It provides access to its RVF Technology for researchers, developers, and biotech companies on a license basis.


TSXV:MIR - Post by User

<< Previous
Bullboard Posts
Next >>
Post by august202013on Mar 20, 2023 10:41am
218 Views
Post# 35348797

HYPOTHETICAL CASE JUST FOR REVIEW

HYPOTHETICAL CASE JUST FOR REVIEWWOULD ANY LONG-TERM MINORITY MEDMIRA SHAREHOLDERS ACCEPT AN OFFER PRICE OF 0.20 CANADIAN CENTS FOR A TAKE OVER BID BY KELVIN LOH OF IHH GROUP? OBVIOUSLY SOME MAY SAY YES BECAUSE CURRENT PRICE IS 0.105 MOST WILL SAY NO JUST BECAUSE AFTER GOOGLING THE BACKGROUND OF THE SUITOR. QUESTION IS WHAT IS THE RIGHT PRICE THAT WILL TRIGGER ALL THE MINORITY SHAREHOLDERS TO AGREE? MAYBE SOME WILL SAY 0.89 OR 0.50 BUT SHOULD'NT KELVIN LOH TRY TO COLLECT AT THESE LEVEL AS MUCH AS POSSIBLE THROUGH A NOMINEE FIRST BEFORE AN OFFER IS MADE OFFICIALLY.

NEXT HURDLE AT WHAT PRICE WILL MM & FAMILY IS WILLING TO EXIT? MOST LIKELY NOT LOWER THAN $1. SO DO THE MATH FELLOW LONG-TERM MEDMIRA SHAREHOLDERS. BEEN PAINFUL TO WAIT BUT THY SHALL BE REWARDED.

THE WAITING CONTINUES.
<< Previous
Bullboard Posts
Next >>